West Chester, PA, United States of America

Nabil A Elshourbagy

USPTO Granted Patents = 27 

 

 

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 53(Granted Patents)


Location History:

  • US (1998)
  • Chester, PA (US) (2017)
  • West Chester, PA (US) (1997 - 2021)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: Innovative Contributions of Nabil A. Elshourbagy in Cardiovascular Treatment

Introduction

Nabil A. Elshourbagy is a noteworthy inventor based in West Chester, PA, known for his significant contributions to the field of cardiovascular disease treatment. With a remarkable portfolio of 26 patents, Elshourbagy's innovations focus on enhancing the management and prevention of cardiovascular conditions, specifically through the modulation of cholesterol levels.

Latest Patents

Among his most recent patents are compounds aimed at inhibiting the proprotein convertase subtilisin kexin type 9 (PCSK9), which plays a crucial role in cholesterol regulation. These compounds provide therapeutic methods for reducing low-density lipoprotein cholesterol (LDL-C) levels and are essential in the treatment and prevention of cardiovascular diseases (CVD), including hypercholesterolemia. The inventive methodologies outlined in these patents showcase the potential to revolutionize cardiovascular treatment protocols.

Career Highlights

Throughout his career, Nabil A. Elshourbagy has made significant strides while working with prominent organizations, including SmithKline Beecham Corporation and Shifa Biomedical Corporation. His experiences at these pharmaceutical companies have enabled him to refine his expertise in drug development and innovation, particularly concerning cardiovascular health.

Collaborations

Elshourbagy has collaborated with notable professionals, including Derk J. Bergsma and Usman Shabon. These partnerships have fostered a collaborative environment for innovation, driving forward creative solutions to pressing healthcare challenges related to cardiovascular diseases.

Conclusion

Nabil A. Elshourbagy's extensive patent portfolio and collaborative efforts highlight his pivotal role in advancing cardiovascular treatment. His dedication to developing compounds and methods that address critical health issues exemplifies the impact that innovative thinking can have on patient care and disease management. As new research and therapies emerge, Elshourbagy's contributions remain a vital part of the ongoing fight against cardiovascular diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…